Formulation and Optimization of Effervescent Tablet Containing Bismuth Sub-citrate
Authors
Abstract
Objective: The objective of this study was to design, evaluate and optimize effervescent tablets containing bismuth sub-citrate with sufficient hardness and friability in treatment of peptic ulcer.
Materials and Methods: Effervescent tablets were prepared by direct compression method and were optimized using irregular factorial design. Amount of citric acid, sodium bicarbonate to citric acid molar ratio, polyvinyl pyrrolidone K 30 (PVP k30), polyethylene glycol 6000 (PEG 6000) were selected as independent variables, whereas disintegration time, amount of carbon dioxide (CO2), friability, pH, and hardness were selected as dependent variables. All the batches were assessed for various pre and post compression characteristics such as flowability, hardness, friability, effervescent time, pH, and content uniformity. For the enhancement of tablets’ palatability, the components of optimized formulation were mixed with same amounts of different flavoring agents.
Results: The best results obtained from effervescent tablets prepared by 500 mg citric acid, 5% PEG 6000 and 3% PVP k30 while the molar ratio of the sodium bicarbonate to citric acid was 3. The disintegration time, amount of CO2, friability, pH, and hardness of optimized formulation were confirmed to be 95.33 ± 1.15 sec, 398.73 ± 1.46 mg, 0.73%, 6.0 ± 0.06 and 72.3 ± 5.5 N, respectively. The most pleasant taste according to volunteers’ acceptability was the taste of cherry.
Conclusion: These results suggest that developed effervescent tablets may be promising for delivery of bismuth sub-citrate in peptic ulcers therapy.
Copyright
© 2019, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
Tayebi H, Mortazavi SA. Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet. Iran J Pharm Res. 2011;10(3):e125934. doi: https://doi.org/10.22037/ijpr.2011.946
Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
Soroush H, Ghorbani-Bidkorbeh F, Mortazavi SA, Mehramizi A. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design. Iran J Pharm Res. 2018;17(4):e124870. doi: https://doi.org/10.22037/ijpr.2018.2318
Design, Formulation and Evaluation of Its Physiochemical Properties of Acetaminophen, Ibuprofen and Caffeine as Effervescent Tablet
Aslani A, Daliri A. Design, Formulation and Evaluation of Its Physiochemical Properties of Acetaminophen, Ibuprofen and Caffeine as Effervescent Tablet. J Rep Pharm Sci. 2016;5(2):e147652. doi:
SUSTAINED RELEASE FORMULATION AND IN-VITRO EVALUATION OF IBUPROFEN-HPMC MATRIX TABLETS
Dabbagh M, Beitmashal L. SUSTAINED RELEASE FORMULATION AND IN-VITRO EVALUATION OF IBUPROFEN-HPMC MATRIX TABLETS. Jundishapur J Nat Pharm Prod. 2006;1(1):. doi:
PREPARATION OF DIAZEPAM RECTAL GEL USING CELLULOSE POLYMERS
Dabbagh M, Ameri A, Honarmand M. PREPARATION OF DIAZEPAM RECTAL GEL USING CELLULOSE POLYMERS. Jundishapur J Nat Pharm Prod. 2007;2(1):. doi:
More by these authors
- Scopus by DOI: 18
Last Update: 2 days ago
- Scopus by Title: 18
Last Update: 2 days ago
- Scopus by Title (Ref): 18
Last Update: 2 days ago
- CrossRef: 16
Last Update: 22 hours ago